Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Primary African Isolates

Novel therapeutic and preventive strategies are needed to contain the HIV-1 epidemic. Broadly neutralizing human antibodies (bNAbs) with exceptional activity against HIV-1 are currently being tested in HIV-1 prevention trials. The selection of anti-HIV-1 bNAbs for clinical development was primarily...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzi, Julio C. C., Mendoza, Pilar, Cohen, Yehuda Z., Nogueira, Lilian, Lavine, Christy, Sapiente, Joseph, Wiatr, Marie, Mugo, Nelly R., Mujugira, Andrew, Delany, Sinead, Lingappa, Jairam, Celum, Connie, Seaman, Michael S., Caskey, Marina, Nussenzweig, Michel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Pathogenesis and Immunity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092834/
https://www.ncbi.nlm.nih.gov/pubmed/33298542
http://dx.doi.org/10.1128/JVI.01909-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092834/
https://www.ncbi.nlm.nih.gov/pubmed/33298542
http://dx.doi.org/10.1128/JVI.01909-20

Ejemplares similares